Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antimicrobial susceptibility, molecular characterization and multilocus sequence typing of Staphylococcus aureus isolates associated with subclinical mastitis in buffaloes (Bubalus bubalis) in Haryana, India.

Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]·2026
Same author

Assessment of Total Delays and Their Associated Factors among Breast, Cervical, and Head and Neck Cancers in Northwestern India: A Cross-Sectional Study.

Asian Pacific journal of cancer prevention : APJCP·2026
Same author

A Qualitative Study of the Lived Experiences and Needs of Parent Caregivers of People With Cystic Fibrosis.

Pediatric pulmonology·2026
Same author

Understanding antimicrobial resistance phenotype in Indian clinical isolates through genomic lens.

Biochemical and biophysical research communications·2026
Same author

In Vivo Assessment of Antimicrobial Potential of Synthetic ANLP-V3 Peptide for the Treatment of Mastitis in a Mouse Model.

Current microbiology·2026
Same author

Assessing Dental Practitioners' Training, Knowledge, and Confidence Regarding Abscesses with Incision and Drainage Procedures: A South Texas Oral Health Network Study.

Texas public health journal·2026

Related Experiment Video

Updated: Jul 5, 2026

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

Balancing Relief and Risk: Managing Chronic Low Back Pain in Patients with Opioid Use Disorder.

Vania Modesto-Lowe1, Deanna Sgambato1, Jasleen Kaur2

  • 1School of Health Sciences, Quinnipiac University, Hamden, Connecticut.

Southern Medical Journal
|July 3, 2026
PubMed
Summary
This summary is machine-generated.

Chronic low back pain and opioid use disorder (OUD) often co-occur, complicating treatment. Integrated care combining medication for OUD with pain management strategies improves patient outcomes by addressing both conditions simultaneously.

More Related Videos

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
06:03

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Published on: July 21, 2023

Related Experiment Videos

Last Updated: Jul 5, 2026

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
06:28

Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation

Published on: December 13, 2024

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits
06:03

Operational and Intervention Effects of Targeted Tuina in Lumbar Intervertebral Disc Degeneration Model Rabbits

Published on: July 21, 2023

Area of Science:

  • Pain Medicine
  • Addiction Medicine
  • Public Health

Background:

  • Chronic low back pain is a leading cause of disability and a primary driver of opioid prescribing.
  • Patients with co-occurring chronic low back pain and opioid use disorder (OUD) face significant barriers to evidence-based, non-opioid treatments.
  • Existing healthcare systems often struggle to manage these complex, comorbid conditions effectively.

Purpose of the Study:

  • To highlight the challenges in managing patients with co-occurring chronic low back pain and opioid use disorder.
  • To advocate for integrated care models that address both conditions concurrently.
  • To propose strategies for improving clinical encounters and patient outcomes.

Main Methods:

  • Review of current clinical guidelines and treatment paradigms for chronic low back pain and OUD.
  • Analysis of systemic barriers, including stigma, fragmented care, and regulatory pressures.
  • Conceptualization of integrated treatment approaches combining medication for OUD with behavioral and rehabilitative pain management.

Main Results:

  • Patients with co-occurring conditions often receive escalating opioid doses due to limited access to alternative therapies.
  • Stigma, system fragmentation, and regulatory issues create significant hurdles for effective care.
  • Integrated care models offer a more practical and effective solution for managing both chronic low back pain and OUD.

Conclusions:

  • Integrated care, combining medication for opioid use disorder with behavioral and rehabilitative pain strategies, is essential for effective management.
  • Focusing on functional improvement, patient safety, and clear communication can enhance care delivery.
  • Addressing structural barriers is crucial for advancing the care of patients with these complex comorbidities.